Skip to main content

Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

Publication ,  Journal Article
Xu, H; Zhang, X; Mannon, RB; Kirk, AD
Published in: J Clin Invest
March 2006

CD154 is a cell surface molecule expressed on activated T cells that binds to CD40, an activating molecule on APCs. Its blockade has been shown to prevent allograft rejection, presumably by interrupting interactions between T cells and APCs. It is known that activated human platelets express and shed CD154 and can induce APC activation and other immune processes in vitro. Here we show that platelet-derived CD154 is sufficient to initiate cardiac allograft rejection independent of any cellular source of this molecule. CD154-KO mice reject cardiac allografts after receiving CD154-expressing human platelets or recombinant CD154 (rCD154) trimers. Treatment with the human CD154-specific mAb 5c8 specifically prevents this induced rejection. Soluble trimers, but not platelets, induce rejection when infused temporally remote from the surgical procedure, suggesting that surgically induced platelet activation is required for CD154 release. Allograft rejection can thus be instigated by activated platelets through CD154. These data implicate platelets as a proximal component of acquired alloimmunity, providing insight into the mechanisms of allograft rejection and the physiological response to trauma in general.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

March 2006

Volume

116

Issue

3

Start / End Page

769 / 774

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Solubility
  • Protein Binding
  • Platelet Transfusion
  • Platelet Activation
  • Mice, Knockout
  • Mice, Inbred C57BL
  • Mice, Inbred BALB C
  • Mice
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu, H., Zhang, X., Mannon, R. B., & Kirk, A. D. (2006). Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest, 116(3), 769–774. https://doi.org/10.1172/JCI27155
Xu, He, Xiaojie Zhang, Roslyn B. Mannon, and Allan D. Kirk. “Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.J Clin Invest 116, no. 3 (March 2006): 769–74. https://doi.org/10.1172/JCI27155.
Xu H, Zhang X, Mannon RB, Kirk AD. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest. 2006 Mar;116(3):769–74.
Xu, He, et al. “Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.J Clin Invest, vol. 116, no. 3, Mar. 2006, pp. 769–74. Pubmed, doi:10.1172/JCI27155.
Xu H, Zhang X, Mannon RB, Kirk AD. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest. 2006 Mar;116(3):769–774.

Published In

J Clin Invest

DOI

ISSN

0021-9738

Publication Date

March 2006

Volume

116

Issue

3

Start / End Page

769 / 774

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Solubility
  • Protein Binding
  • Platelet Transfusion
  • Platelet Activation
  • Mice, Knockout
  • Mice, Inbred C57BL
  • Mice, Inbred BALB C
  • Mice
  • Male